Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-12-18 / Vaccine 2011 Feb;29(6):1185-93Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-12-13 / J. Clin. Oncol. 2011 Jan;29(3):330-6Guiding the „misguided“ – functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
/in Dendritic Cells, International Publications /von 2010-12-09 / Eur. J. Immunol. 2011 Jan;41(1):18-25Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
/in Dendritic Cells, Glioblastoma, International Publications /von 2010-12-06 / Clin. Cancer Res. 2011 Mar;17(6):1603-15Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-12-01 / Anticancer Res. 2010 Dec;30(12):5091-7Transcriptome analysis and cytokine profiling of naive T cells stimulated by a tumor vaccine via CD3 and CD25
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-12-01 / Int. J. Oncol. 2010 Dec;37(6):1439-52New approaches to the development of adenoviral dendritic cell vaccines in melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-408Effect of hyperthermia on the apoptosis and proliferation of CaSki cells
/in Cervical Cancer, Hyperthermia, International Publications /von 2010-11-30 / Mol Med Rep 2011 Jan-Feb;4(1):187-91Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?
/in Hyperthermia, International Publications /von 2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1161, 1166Hyperthermia as a treatment for bladder cancer
/in Hyperthermia, International Publications /von 2010-11-15 / Oncology (Williston Park, N.Y.) 2010 Nov;24(12):1149-55Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
/in Breast Cancer, Hyperthermia, International Publications /von 2010-11-11 / Radiother Oncol 2010 Dec;97(3):535-40Hyperthermia enhances the effect of β-lapachone to cause γH2AX formations and cell death in human osteosarcoma cells
/in Hyperthermia, International Publications /von 2010-11-11 / Int J Hyperthermia 2011;27(1):53-62An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Jan;60(1):87-97Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2010-11-08 / Strahlenther Onkol 2010 Nov;186(11):587-99NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment
/in Hyperthermia, International Publications /von 2010-11-08 / Proc. Natl. Acad. Sci. U.S.A. 2010 Nov;107(47):20477-82Dendritic cell-based immunotherapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-11-04 / Clin. Dev. Immunol. 2010;2010:517493Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
/in International Publications, Newcastle Disease Virus /von 2010-11-04 / Head Neck 2011 Oct;33(10):1394-9Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
/in Dendritic Cells, International Publications /von 2010-11-01 / Expert Opin Biol Ther 2010 Nov;10(11):1539-53The role of hyperthermia in the battle against cancer
/in Hyperthermia, International Publications /von 2010-11-01 / Tumori 2010 Nov-Dec;96(6):902-10